• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

越南卫生技术评估发展:当前进展、障碍、促进因素和未来战略的定性研究。

Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.

机构信息

Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.

Institute of Convergence Science (ICONS), Convergence Science Academy, Yonsei University, Seoul 03722, Korea.

出版信息

Int J Environ Res Public Health. 2021 Aug 22;18(16):8846. doi: 10.3390/ijerph18168846.

DOI:10.3390/ijerph18168846
PMID:34444597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8392551/
Abstract

INTRODUCTION

To make more efficient use of limited resources, Vietnam incorporated health technology assessment (HTA) into the decision-making process for the health insurance benefit package in 2014. We evaluated progress in HTA institutionalization in Vietnam based on the theoretical framework developed by the National Institute for Health and Care Excellence and the Health Intervention and Technology Assessment Program, identified negative and conducive factors for HTA development, and finally suggested policy recommendations that fit the Vietnamese context.

METHODS

Semi-structured in-depth qualitative interviews were conducted between December 2017 and March and April 2018 with a purposive sample of 24 stakeholders involved in decision-making for health insurance reimbursement. We employed thematic analysis to examine themes within the data.

RESULTS

Despite a variety of activities (e.g., training and advising/mentoring) and a substantial level of output (e.g., policy statements, focal points assigned, and case studies/demonstration projects), Vietnam has not yet reached the policy decision stage based on HTA with scientific integrity and active stakeholder participation. Most respondents, except some clinicians, supported the use of HTA. The lack of capacity of human resources in the government sector and academia, the limited data infrastructure, the absence of guidelines, the government's interest in immediate budget-saving, and public resistance were identified as barriers to the advancement of HTA.

CONCLUSIONS

A structured data repository, guidelines based on the Vietnamese context for both policy decision-making at the central level and daily clinical decision-making at the micro-level, and integration of a participatory process into HTA are suggested as priorities for HTA institutionalization in Vietnam.

摘要

简介

为了更有效地利用有限的资源,越南于 2014 年将卫生技术评估(HTA)纳入医疗保险福利包的决策过程。我们根据国家卫生与保健卓越研究所和卫生干预与技术评估计划制定的理论框架,评估了越南 HTA 制度化的进展情况,确定了 HTA 发展的不利和有利因素,最后提出了符合越南国情的政策建议。

方法

2017 年 12 月至 2018 年 3 月和 4 月,我们对 24 名参与医疗保险报销决策的利益攸关方进行了半结构式深入定性访谈。我们采用主题分析方法来审查数据中的主题。

结果

尽管开展了各种活动(例如培训和提供建议/指导),并且取得了相当多的成果(例如政策声明、指定的联络点以及案例研究/示范项目),但越南尚未根据具有科学完整性和积极利益攸关方参与的 HTA 做出政策决策。除了一些临床医生外,大多数受访者都支持使用 HTA。政府部门和学术界人力资源能力不足、数据基础设施有限、缺乏指南、政府对节省预算的兴趣以及公众的抵制被认为是 HTA 发展的障碍。

结论

建议将建立结构化的数据存储库、基于越南国情的指南(用于中央层面的政策决策和微观层面的日常临床决策)以及将参与性过程纳入 HTA 作为越南 HTA 制度化的优先事项。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e41/8392551/b6f52912f4a3/ijerph-18-08846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e41/8392551/b6f52912f4a3/ijerph-18-08846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e41/8392551/b6f52912f4a3/ijerph-18-08846-g001.jpg

相似文献

1
Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.越南卫生技术评估发展:当前进展、障碍、促进因素和未来战略的定性研究。
Int J Environ Res Public Health. 2021 Aug 22;18(16):8846. doi: 10.3390/ijerph18168846.
2
Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.卫生技术评估和全民健康覆盖的优先事项制定:尼日利亚利益攸关方能力、需求、政策领域需求和观点的定性研究。
Global Health. 2020 Jul 8;16(1):58. doi: 10.1186/s12992-020-00583-2.
3
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
4
Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.运用最佳-最差标度法评估奥地利卫生技术评估使用过程中最重要的障碍因素和促进因素。
Expert Rev Pharmacoecon Outcomes Res. 2018 Apr;18(2):223-232. doi: 10.1080/14737167.2017.1375407. Epub 2017 Sep 8.
5
Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.探索伊朗卫生技术评估的全貌:利益相关者对需求、需求和供应的看法。
Health Res Policy Syst. 2024 Jan 15;22(1):11. doi: 10.1186/s12961-023-01097-0.
6
STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.国家层面利益相关者参与卫生技术评估:来自伊朗的一项研究
Int J Technol Assess Health Care. 2016 Jan;32(3):181-9. doi: 10.1017/S0266462316000167. Epub 2016 Aug 15.
7
The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.HTA 在印度尼西亚医药定价和报销政策中的实施:来自多方利益相关者的观点。
PLoS One. 2019 Nov 27;14(11):e0225626. doi: 10.1371/journal.pone.0225626. eCollection 2019.
8
The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.2003 - 2013年英国国家卫生研究院卫生技术评估项目的影响:多方法评估
Health Technol Assess. 2015 Aug;19(67):1-291. doi: 10.3310/hta19670.
9
Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.通过建立卫生干预和技术评估计划加强泰国的成本效益分析。
Pharmacoeconomics. 2009;27(11):931-45. doi: 10.2165/11314710-000000000-00000.
10
Factors influencing institutionalization of health technology assessment in Kenya.影响肯尼亚卫生技术评估制度化的因素。
BMC Health Serv Res. 2023 Jun 22;23(1):681. doi: 10.1186/s12913-023-09673-4.

引用本文的文献

1
Challenges in adopting health technology assessment for evidence-based policy in Iran: a qualitative study.伊朗在采用卫生技术评估以制定循证政策方面面临的挑战:一项定性研究。
J Health Popul Nutr. 2025 Apr 23;44(1):134. doi: 10.1186/s41043-025-00887-2.
2
Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives.应对伊朗卫生技术评估发展的障碍:对利益相关者观点的定性探索。
Arch Public Health. 2025 Mar 27;83(1):83. doi: 10.1186/s13690-025-01566-8.
3
Assessing the development of health technology assessment in Iran: a policy analysis using Kingdon's Multiple streams framework: a qualitative study.

本文引用的文献

1
Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam.越南慢性丙型肝炎基因型 1 和 6 直接作用抗病毒药物治疗的成本效用分析。
Value Health. 2020 Sep;23(9):1180-1190. doi: 10.1016/j.jval.2020.03.018. Epub 2020 Jul 20.
2
The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessment.加纳决策者和研究人员对卫生技术评估的知识与态度。
Soc Sci Med. 2020 Feb 29;250:112889. doi: 10.1016/j.socscimed.2020.112889.
3
Analysis of a Small Group of Stakeholders Regarding Advancing Health Technology Assessment in India.
评估伊朗卫生技术评估的发展:一项使用金登多源流框架的政策分析:一项定性研究。
BMC Public Health. 2025 Jan 20;25(1):226. doi: 10.1186/s12889-025-21465-5.
4
Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries.弥合现实世界的数据差距:连接10个亚洲国家的数据点。
JMIR Med Inform. 2024 Aug 15;12:e58548. doi: 10.2196/58548.
5
The Experiences of Strategic Purchasing of Healthcare in Nine Middle-Income Countries: A Systematic Qualitative Review.九国中医疗保健战略采购的经验:系统定性评价。
Int J Health Policy Manag. 2023;12:7352. doi: 10.34172/ijhpm.2023.7352. Epub 2023 Nov 6.
6
Pedestrians' Perception of Pedestrian Bridges-A Qualitative Study in Dar es Salaam.行人对行人天桥的感知——达累斯萨拉姆的定性研究。
Int J Environ Res Public Health. 2022 Jan 22;19(3):1238. doi: 10.3390/ijerph19031238.
关于推进印度卫生技术评估的一小部分利益相关者分析
Value Health Reg Issues. 2014 May;3:167-171. doi: 10.1016/j.vhri.2014.04.006. Epub 2014 May 21.
4
Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE.低收入和中等收入国家的卫生技术评估能力建设:来自泰国健康促进基金会(HITAP)和英国国家卫生与临床优化研究所(NICE)国际部门的经验
F1000Res. 2017 Dec 11;6:2119. doi: 10.12688/f1000research.13180.1. eCollection 2017.
5
Thresholds for the cost-effectiveness of interventions: alternative approaches.干预措施成本效益的阈值:替代方法
Bull World Health Organ. 2015 Feb 1;93(2):118-24. doi: 10.2471/BLT.14.138206. Epub 2014 Dec 15.
6
A systematic review of scope and quality of health economic evaluation studies in Vietnam.越南卫生经济评估研究的范围和质量的系统评价。
PLoS One. 2014 Aug 14;9(8):e103825. doi: 10.1371/journal.pone.0103825. eCollection 2014.
7
Bridging the gap between the economic evaluation literature and daily practice in occupational health: a qualitative study among decision-makers in the healthcare sector.弥合经济评估文献与职业健康实践之间的差距:医疗保健领域决策者的定性研究。
Implement Sci. 2013 Jun 3;8:57. doi: 10.1186/1748-5908-8-57.
8
A systematic review of coverage decision-making on health technologies-evidence from the real world.一项关于卫生技术覆盖决策的系统评价——来自真实世界的证据。
Health Policy. 2012 Oct;107(2-3):218-30. doi: 10.1016/j.healthpol.2012.07.005. Epub 2012 Aug 4.
9
Pharmaceutical priority setting and the use of health economic evaluations: a systematic literature review.药物优先配置和卫生经济评估的应用:系统文献回顾。
Value Health. 2011 Jun;14(4):587-99. doi: 10.1016/j.jval.2010.10.036. Epub 2011 Apr 30.
10
Eliciting ethical and social values in health technology assessment: A participatory approach.健康技术评估中伦理和社会价值的引出:一种参与式方法。
Soc Sci Med. 2011 Jul;73(1):135-44. doi: 10.1016/j.socscimed.2011.04.017. Epub 2011 May 23.